Activation of the poly(ADP-ribose) polymerase pathway in human heart failure

Andrea Molnár, Attila Tóth, Zsolt Bagi, Zoltán Papp, István Édes, Miklós Vaszily, Zoltán Galajda, Julius Gy Papp, András Varró, Viktória Szüts, Zsombor Lacza, Domokos Gerö, Csaba Szabó

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Poly(ADP-ribose) polymerase (PARP) activation has been implicated in the pathogenesis of acute and chronic myocardial dysfunction and heart failure. The goal of the present study was to investigate PARP activation in human heart failure, and to correlate PARP activation with various indices of apoptosis and oxidative and nitrosative stress in healthy (donor) and failing (NYHA class III-IV) human heart tissue samples. Higher levels of oxidized protein end-products were found in failing hearts compared with donor heart samples. On the other hand, no differences in tyrosine nitration (a marker of peroxynitrite generation) were detected. Activation of PARP was demonstrated in the failing hearts by an increased abundance of poly-ADP ribosylated proteins. Immunohistochemical analysis revealed that PARP activation was localized to the nucleus of the cardiomyocytes from the failing hearts. The expression of full-length PARP-1 was not significantly different in donor and failing hearts. The expression of caspase-9, in contrast, was significantly higher in the failing than in the donor hearts. Immunohistochemical analysis was used to detect the activation of mitochondrial apoptotic pathways. We found no significant translocation of apoptosis-inducing factor (AIF) into the nucleus. Overall, the current data provide evidence of oxidative stress and PARP activation in human heart failure. Interventional studies with antioxidants or PARP inhibitors are required to define the specific roles of these factors in the pathogenesis of human heart failure.

Original languageEnglish (US)
Pages (from-to)143-152
Number of pages10
JournalMolecular Medicine
Volume12
Issue number7-8
DOIs
StatePublished - Jul 1 2006

Fingerprint

Poly(ADP-ribose) Polymerases
Heart Failure
Oxidative Stress
Apoptosis Inducing Factor
Peroxynitrous Acid
Caspase 9
Cardiac Myocytes
Tyrosine
Antioxidants
Apoptosis

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Molnár, A., Tóth, A., Bagi, Z., Papp, Z., Édes, I., Vaszily, M., ... Szabó, C. (2006). Activation of the poly(ADP-ribose) polymerase pathway in human heart failure. Molecular Medicine, 12(7-8), 143-152. https://doi.org/10.2119/2006-00043.Molnar

Activation of the poly(ADP-ribose) polymerase pathway in human heart failure. / Molnár, Andrea; Tóth, Attila; Bagi, Zsolt; Papp, Zoltán; Édes, István; Vaszily, Miklós; Galajda, Zoltán; Papp, Julius Gy; Varró, András; Szüts, Viktória; Lacza, Zsombor; Gerö, Domokos; Szabó, Csaba.

In: Molecular Medicine, Vol. 12, No. 7-8, 01.07.2006, p. 143-152.

Research output: Contribution to journalArticle

Molnár, A, Tóth, A, Bagi, Z, Papp, Z, Édes, I, Vaszily, M, Galajda, Z, Papp, JG, Varró, A, Szüts, V, Lacza, Z, Gerö, D & Szabó, C 2006, 'Activation of the poly(ADP-ribose) polymerase pathway in human heart failure', Molecular Medicine, vol. 12, no. 7-8, pp. 143-152. https://doi.org/10.2119/2006-00043.Molnar
Molnár, Andrea ; Tóth, Attila ; Bagi, Zsolt ; Papp, Zoltán ; Édes, István ; Vaszily, Miklós ; Galajda, Zoltán ; Papp, Julius Gy ; Varró, András ; Szüts, Viktória ; Lacza, Zsombor ; Gerö, Domokos ; Szabó, Csaba. / Activation of the poly(ADP-ribose) polymerase pathway in human heart failure. In: Molecular Medicine. 2006 ; Vol. 12, No. 7-8. pp. 143-152.
@article{ee51fe66c84341f49e59eb6ae7e05100,
title = "Activation of the poly(ADP-ribose) polymerase pathway in human heart failure",
abstract = "Poly(ADP-ribose) polymerase (PARP) activation has been implicated in the pathogenesis of acute and chronic myocardial dysfunction and heart failure. The goal of the present study was to investigate PARP activation in human heart failure, and to correlate PARP activation with various indices of apoptosis and oxidative and nitrosative stress in healthy (donor) and failing (NYHA class III-IV) human heart tissue samples. Higher levels of oxidized protein end-products were found in failing hearts compared with donor heart samples. On the other hand, no differences in tyrosine nitration (a marker of peroxynitrite generation) were detected. Activation of PARP was demonstrated in the failing hearts by an increased abundance of poly-ADP ribosylated proteins. Immunohistochemical analysis revealed that PARP activation was localized to the nucleus of the cardiomyocytes from the failing hearts. The expression of full-length PARP-1 was not significantly different in donor and failing hearts. The expression of caspase-9, in contrast, was significantly higher in the failing than in the donor hearts. Immunohistochemical analysis was used to detect the activation of mitochondrial apoptotic pathways. We found no significant translocation of apoptosis-inducing factor (AIF) into the nucleus. Overall, the current data provide evidence of oxidative stress and PARP activation in human heart failure. Interventional studies with antioxidants or PARP inhibitors are required to define the specific roles of these factors in the pathogenesis of human heart failure.",
author = "Andrea Moln{\'a}r and Attila T{\'o}th and Zsolt Bagi and Zolt{\'a}n Papp and Istv{\'a}n {\'E}des and Mikl{\'o}s Vaszily and Zolt{\'a}n Galajda and Papp, {Julius Gy} and Andr{\'a}s Varr{\'o} and Vikt{\'o}ria Sz{\"u}ts and Zsombor Lacza and Domokos Ger{\"o} and Csaba Szab{\'o}",
year = "2006",
month = "7",
day = "1",
doi = "10.2119/2006-00043.Molnar",
language = "English (US)",
volume = "12",
pages = "143--152",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "7-8",

}

TY - JOUR

T1 - Activation of the poly(ADP-ribose) polymerase pathway in human heart failure

AU - Molnár, Andrea

AU - Tóth, Attila

AU - Bagi, Zsolt

AU - Papp, Zoltán

AU - Édes, István

AU - Vaszily, Miklós

AU - Galajda, Zoltán

AU - Papp, Julius Gy

AU - Varró, András

AU - Szüts, Viktória

AU - Lacza, Zsombor

AU - Gerö, Domokos

AU - Szabó, Csaba

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Poly(ADP-ribose) polymerase (PARP) activation has been implicated in the pathogenesis of acute and chronic myocardial dysfunction and heart failure. The goal of the present study was to investigate PARP activation in human heart failure, and to correlate PARP activation with various indices of apoptosis and oxidative and nitrosative stress in healthy (donor) and failing (NYHA class III-IV) human heart tissue samples. Higher levels of oxidized protein end-products were found in failing hearts compared with donor heart samples. On the other hand, no differences in tyrosine nitration (a marker of peroxynitrite generation) were detected. Activation of PARP was demonstrated in the failing hearts by an increased abundance of poly-ADP ribosylated proteins. Immunohistochemical analysis revealed that PARP activation was localized to the nucleus of the cardiomyocytes from the failing hearts. The expression of full-length PARP-1 was not significantly different in donor and failing hearts. The expression of caspase-9, in contrast, was significantly higher in the failing than in the donor hearts. Immunohistochemical analysis was used to detect the activation of mitochondrial apoptotic pathways. We found no significant translocation of apoptosis-inducing factor (AIF) into the nucleus. Overall, the current data provide evidence of oxidative stress and PARP activation in human heart failure. Interventional studies with antioxidants or PARP inhibitors are required to define the specific roles of these factors in the pathogenesis of human heart failure.

AB - Poly(ADP-ribose) polymerase (PARP) activation has been implicated in the pathogenesis of acute and chronic myocardial dysfunction and heart failure. The goal of the present study was to investigate PARP activation in human heart failure, and to correlate PARP activation with various indices of apoptosis and oxidative and nitrosative stress in healthy (donor) and failing (NYHA class III-IV) human heart tissue samples. Higher levels of oxidized protein end-products were found in failing hearts compared with donor heart samples. On the other hand, no differences in tyrosine nitration (a marker of peroxynitrite generation) were detected. Activation of PARP was demonstrated in the failing hearts by an increased abundance of poly-ADP ribosylated proteins. Immunohistochemical analysis revealed that PARP activation was localized to the nucleus of the cardiomyocytes from the failing hearts. The expression of full-length PARP-1 was not significantly different in donor and failing hearts. The expression of caspase-9, in contrast, was significantly higher in the failing than in the donor hearts. Immunohistochemical analysis was used to detect the activation of mitochondrial apoptotic pathways. We found no significant translocation of apoptosis-inducing factor (AIF) into the nucleus. Overall, the current data provide evidence of oxidative stress and PARP activation in human heart failure. Interventional studies with antioxidants or PARP inhibitors are required to define the specific roles of these factors in the pathogenesis of human heart failure.

UR - http://www.scopus.com/inward/record.url?scp=33750455151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750455151&partnerID=8YFLogxK

U2 - 10.2119/2006-00043.Molnar

DO - 10.2119/2006-00043.Molnar

M3 - Article

C2 - 17088946

AN - SCOPUS:33750455151

VL - 12

SP - 143

EP - 152

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 7-8

ER -